Varicella vaccination in Europe: are we ready for a universal childhood programme?
about
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccineHerpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccineImmune modulation during latent herpesvirus infectionImmunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.Varicella vaccination in Europe - taking the practical approach.Computational modeling of interventions and protective thresholds to prevent disease transmission in deploying populationsA proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.Successes and challenges in varicella vaccineThe humanistic, economic and societal burden of herpes zoster in Europe: a critical reviewVaricella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trialShould the UK introduce varicella vaccine?Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?Shingles vaccination: background and advice for community nurses.Vaccination coverage among adolescents and risk factors associated with incomplete immunization.Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis.
P2860
Q21089976-642F057C-B47C-4C47-A029-277B7B6D1128Q21562177-C3D42300-520F-4523-A467-68A79FF4FB31Q24624044-F7E84A6F-8EAF-4365-A574-1AFDD38811CAQ33430135-AD387FCA-FD06-4DBB-807F-7D064A22D0D1Q33454919-3AFDC6F2-629C-4EC8-AAAA-1F1213F1D07BQ33804835-5AA02F92-2D58-43C0-AA2E-944EC19D51D1Q33923167-18000DD8-9C5F-4C3B-8DE3-B241BE632725Q34101345-619FF683-88F9-40BD-858B-026A7FCE3B2AQ34313029-D8AAA50E-D26F-4553-A96F-CA4E981B2B68Q34416710-AF26F165-9CB0-4D67-88EB-9B8D136028B3Q35147612-74466ACD-7E84-49CB-B2FA-EC818955D93DQ35893127-345702B6-BF9E-4CEC-9C8C-4BB6B57F84ACQ36121450-403B6C1F-482E-48DC-BBEC-37BCB806AFF5Q37660930-37E40FB3-E43E-429D-98D7-29C1679026F9Q38245786-9A3864DF-F000-4F9F-A304-8BD08F76C839Q39977898-7C243C38-9516-4B14-ADBC-FE1D7FF8B2ECQ40437635-E6B66BE2-1897-409E-A4BC-8545B94DE6BCQ46941948-2C7B5626-63D2-4BAF-864C-2E8B6BCFD2C0
P2860
Varicella vaccination in Europe: are we ready for a universal childhood programme?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@en
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@nl
type
label
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@en
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@nl
prefLabel
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@en
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@nl
P2093
P2860
P50
P1476
Varicella vaccination in Europe: are we ready for a universal childhood programme?
@en
P2093
Aisha Jumaan
Catherine Weil-Olivier
H J Schmitt
Heikki Peltola
Jane Seward
Nancy Thiry
Nitu Sengupta
Pierre Van-Damme
P2860
P2888
P356
10.1007/S00431-007-0424-0
P577
2007-03-03T00:00:00Z